HilleVax (HLVX) Expected to Announce Quarterly Earnings on Wednesday

HilleVax (NASDAQ:HLVX) is expected to be posting its quarterly earnings results before the market opens on Wednesday, March 19th. Analysts expect HilleVax to post earnings of ($0.38) per share for the quarter.

HilleVax Stock Performance

HLVX opened at $1.78 on Wednesday. The company has a fifty day moving average price of $1.91 and a two-hundred day moving average price of $1.88. The firm has a market capitalization of $88.65 million, a PE ratio of -0.57 and a beta of 0.76. HilleVax has a 52 week low of $1.55 and a 52 week high of $18.42.

HilleVax Company Profile

HilleVax, Inc, a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. It develops HIL-214, a virus-like particle-based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis caused by norovirus infection. The company was formerly known as MokshaCo, Inc and changed its name to HilleVax, Inc in February 2021.